A Microneedle Pill as an Alternative to Injectable Drug
Carl Schoellhammerhas just won the Lemelson-MIT National Collegiate Student Prize for his invention - the microneedle pill.
Search for Terms or Answers
Carl Schoellhammerhas just won the Lemelson-MIT National Collegiate Student Prize for his invention - the microneedle pill.
A population based study from Taiwan shows that Sjogren's syndrome, to have a prevalence of 0.05%. The prevalence of the syndrome, however, was 10 times higher among women (0.10%) compared to men (0.01%). Overall, having an affected first-degree relative with Sjogren's syndrome carried
Study by Dashkova et al finds males less likely to have their bone density checked, but suffered worse outcomes. "We were surprised at how big a difference we found between men and women regarding osteoporosis," study author Dr.
The danger model was proposed by Matzinger as an alternative (or complement) to the traditional self-non-self (SNS) model of autoimmunity.
The FDA has granted adalimumab (Humira) orphan drug designation for the investigational treatment of moderate-to-severe hidradenitis suppurativa (HS) (Hurley Stage II and Hurley Stage III disease).
"As scholars of disease have noted, RA today appears to be a less severe disease than it was when I started my career in the 1970s. Then, patients routinely ‘went up in smoke’ and rapidly became crippled, wasting away in a state we called ‘burnt out’.
Lancet article on the increasing prevalence of gout shows a rate of 2.5% in the UK that has increased 67% in the last 15 years.
Pooled analyses of the tanezumab (a nerve growth factor inhibitor) phase 3 studies was presented at the 2015 Osteoarthritis Research Society International (OARSI) World Congress.
A Finnish early RA register studied 14,878 incident RA patients from 2000-2008 and identified 1157 deaths. Patients receiving DMARDs and MTX had lower mortality rates. The standardized moratility ratio for the entire cohort was reduced (0.57, 95% CI 0.52 to 0.62).
HLA-B27 is found 6.1% of the US population, but with is seen in >90% patients with ankylosing spondylitis. HLA-B27 increases risk of spondylitis, uveitis and heart block. [Image credit: "HLA-B*2705" by Pdeitiker - Own work. Licensed under Public Domain via Wikimedia Commons]
According to the Federal Trade Commission biosimilars have the potential to save the U.S. healthcare system $250 billion through 2022.
Hepatic enzyme elevations with TNF inhibitor use is not uncommon.
The defining triad of Blau's syndrome includes granulomatous polyarthritis, dermatitis and uveitis. This rare, monogenic, autosomal dominant disorder stems from a "gain in function" mutation of the pattern recognition receptor NOD2.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.